We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
BLOK is a multi-disciplinary studio and digital fitness platform. The company's first site in Clapton, Hackney opened in Q1 of 2016, followed by Shoreditch in 2018, and Manchester in 2019. In May 2020, BLOK launched BLOKtv. This launch led to nearly 2,000 people joining BLOK's classes each week with more customers joining in from 134 countries. The digital fitness market has experienced an annual growth of 33% since 2017, and BLOK aims to be the market leader in this segment. The company has hosted global stars such as Anthony Joshua, Jourdan Dunn, Kayla Itsines, Conor Benn and Alicia Vikander. BLOK's studios have also featured on programmes such as 'Britain's Next Top Model' and 'Made in Chelsea'. The company raised over £891,000 from 571 investors on Crowdcube in 2018. It will use the investment to accelerate the growth of BLOKtv and further build its digital community.
days to go: Expired investment: £536,163
JustUs plans to offer its own ISA's directly to consumers via IFA's and by doing so they are disrupting the £1.5 trillion lending and savings market in the UK. 
days to go: Expired investment: £12,580
Qynn is an investment opportunity and the world’s foremost provider of corporate information and insight on the unlisted UK SME market. The company has four live products: Hunter, QBase, Playground, and Qynn Score. In the next six months, the company will release many new products to multiply the current data stack. Qynn aims at creating the world's most advanced company search tool. With the proceeds, the company will be able to drive sales and product development.
days to go: Expired investment: £310,009
Assetz Capital is an FCA authorized, major business secured by property and P2P lender in the Europe and UK. Funded by 30,000+ lenders, the company provides loans to property developers and SMEs in the UK. Assetz Capital was ranked 53rd out of the UK’s top 100 fastest-growing technology companies in the Sunday Times Tech Track 100. Moreover, the company has witnessed a 78% average revenue growth over three years. Having achieved critical mass and proven business model, Assetz Capital is headed towards meeting the multi-billion funding gap faced by SMEs. With the proceeds, the company will strengthen the cash levels and balance sheet and provide further opportunities to shareholders and customers.
days to go: Expired investment: £1,866,500
Prosper is creating a customer-focused brand, aiming to offer free access to public and private funds, competitive cash rates, and instant financial advice via a mobile app. They charge a platform fee based on the customer's assets. The experienced team behind successful ventures like Tandem Bank and Nutmeg is targeting the UK's expensive and underperforming savings and investment market. They've raised £3.2 million from investors including Tom Blomfield (Monzo) and Charlie Delingpole (ComplyAdvantage).
days to go: Expired investment: £1,022,665
Nextfin is an FCA approved aggregation and rating portal for equity and debt crowdfunding investments. AIM is shrinking, legacy stock markets are too expensive to maintain and do not serve the requirements of SMEs, banks are closing branches, lending less and are paying little or no interest to investors. As a result of this, there is a huge growth in equity crowdfunding and P2P lending which has seen the launch of hundreds of alternative lenders & platforms that has created a new c.£3bn marketplace, expanding at 66% p.a. There is no single portal or trusted ratings index for investors to compare on a like for like basis and no secondary market to facilitate exits. * NextFin is the new trading name of Business Agent Ltd The solution NextFin aggregates equity and debt crowdfunding investments to create the alternative finance marketplace. This makes it easy for investors and lenders to find and compare opportunities by presenting all investment offerings in one place. With the addition of a free of charge ratings service investors will be able to view ratings of every equity crowdfunding pitch, every P2P site, and every equity crowdfunding site. NextFin’s technology will constantly track these companies and investments providing the investor real-time intelligence on which to base investment decisions. The platforms and entrepreneurs will be self-promoting and marketing their ratings driving thousands of visitors a month to the NextFin site, in the same way, businesses refer their potential clients to Trip Advisor and Trustpilot. There is an estimated 10 million website/platform visitors per month across the whole of the alternative finance market. NextFin is targeting to direct 5% of this highly profiled traffic to its platform from which it will earn between £5-£8 per click from advertisers and partners. In addition, an in-house brokerage service also earns between 1%-6% commissions on loan placements. A future revenue stream (not featured in the financials) will be developed once visitor traffic reaches critical mass. This will see Nextfin being able to realise the full value of its captured ratings data and visitor traffic by launching a secondary market, which is estimated to be a £5bn marketplace. NextFin is raising £500k at a pre-money valuation of £2M to: • Develop P2P and Equity site ratings• Expand the management, infrastructure and marketing resource• Increase visitor traffic to 6m a year via rating referrals Owing to the size of the market and rapid growth of the industry, enterprise valuations in alternative finance are based on visitor traffic, market share and registered users. Recently published valuations of companies with visitor traffic of over 6m per year are in excess of £70m. NextFin is the market-leading aggregator and has first-mover advantage. It has the potential to exceed these valuations because it is the whole of the market aggregator and is currently the only ratings service provider as it grows to achieve 500,000 visitors p.m.

Pitch Rated

71%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £274,057
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph